Dosing & Uses
Dosage Forms & Strengths
pentazocine/naloxone
tablet: Schedule IV
- 50mg/0.5mg
Moderate-to-Severe Pain
1 tablet PO q3-4hr, may increase to 2 tablets q3-4hr PRN; not to exceed 12 tablets/day
Renal Impairment
CrCl 10-50 mL/min: 75% regular adult dose
CrCl <10 mL/min: 50% regular adult dose
Hepatic Impairment
Use caution
Dosage Forms & Strengths
pentazocine/naloxone
tablet: Schedule IV
- 50mg/0.5mg
Moderate-to-Severe Pain
<12 years: Safety and efficacy not established
>12 years: As adults; tablet PO q3-4hr, may increase to 2 tablets q3-4hr PRN; not to exceed 12 tablets/day
Use caution; monitor closely
Moderate-to-Severe Pain
1 tablet PO q3-4hr, may increase to 2 tablets q3-4hr PRN; not to exceed 12 tablets/day
Interactions
Interaction Checker
No Results

Contraindicated
Serious - Use Alternative
Significant - Monitor Closely
Minor

Contraindicated (1)
- alvimopan
alvimopan, pentazocine. receptor binding competition. Contraindicated. Alvimopan is contraindicated in opioid tolerant patients (ie, those who have taken therapeutic doses of opioids for >7 consecutive days immediately prior to taking alvimopan). Patients recently exposed to opioids are expected to be more sensitive to the effects of alvimopan and therefore may experience abdominal pain, nausea and vomiting, and diarrhea. No significant interaction is expected with concurrent use of opioid analgesics and alvimopan in patients who received opioid analgesics for 7 or fewer consecutive days prior to alvimopan.
Serious - Use Alternative (56)
- alfentanil
pentazocine, alfentanil. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- belladonna and opium
pentazocine, belladonna and opium. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- benzhydrocodone/acetaminophen
benzhydrocodone/acetaminophen, pentazocine. Either increases toxicity of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Profound sedation, respiratory depression, coma, and death may result if coadministered. Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate. Limit dosages and durations to the minimum required. Monitor closely for signs of respiratory depression and sedation.
pentazocine decreases effects of benzhydrocodone/acetaminophen by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Mixed opioid agonists/antagonists and partial opioid agonists may reduce the analgesic effect of hydrocodone (benzhydrocodone prodrug of hydrocodone) and/or precipitate withdrawal symptoms in opioid tolerant patients.
benzhydrocodone/acetaminophen and pentazocine both increase sedation. Avoid or Use Alternate Drug. Limit use to patients for whom alternative treatment options are inadequate - bremelanotide
bremelanotide will decrease the level or effect of pentazocine by Other (see comment). Avoid or Use Alternate Drug. Bremelanotide may slow gastric emptying and potentially reduces the rate and extent of absorption of concomitantly administered oral medications. Avoid use when taking any oral drug that is dependent on threshold concentrations for efficacy. Interactions listed are representative examples and do not include all possible clinical examples.
- buprenorphine
buprenorphine, pentazocine. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- buprenorphine buccal
buprenorphine buccal, pentazocine. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- buprenorphine subdermal implant
buprenorphine subdermal implant and pentazocine both increase sedation. Avoid or Use Alternate Drug. Limit use to patients for whom alternative treatment options are inadequate
- buprenorphine transdermal
buprenorphine transdermal and pentazocine both increase sedation. Avoid or Use Alternate Drug. Limit use to patients for whom alternative treatment options are inadequate
- buprenorphine, long-acting injection
buprenorphine, long-acting injection and pentazocine both increase sedation. Avoid or Use Alternate Drug. Limit use to patients for whom alternative treatment options are inadequate
- butorphanol
butorphanol, pentazocine. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- calcium/magnesium/potassium/sodium oxybates
pentazocine, calcium/magnesium/potassium/sodium oxybates. Either increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Profound sedation, respiratory depression, coma, and death may result if coadministered. Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate. Limit dosages and durations to the minimum required. Monitor closely for signs of respiratory depression and sedation.
- cimetidine
cimetidine increases effects of pentazocine by decreasing metabolism. Avoid or Use Alternate Drug.
- clonidine
clonidine, pentazocine. Either increases toxicity of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Coadministration enhances CNS depressant effects.
- codeine
pentazocine, codeine. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- desvenlafaxine
pentazocine and desvenlafaxine both increase serotonin levels. Avoid or Use Alternate Drug.
- dextromoramide
pentazocine, dextromoramide. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- diamorphine
pentazocine, diamorphine. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- diazepam intranasal
diazepam intranasal, pentazocine. Either increases toxicity of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Profound sedation, respiratory depression, coma, and death may result if coadministered. Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate. Limit dosages and durations to the minimum required. Monitor closely for signs of respiratory depression and sedation.
- difenoxin hcl
pentazocine, difenoxin hcl. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- diphenoxylate hcl
pentazocine, diphenoxylate hcl. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- dipipanone
pentazocine, dipipanone. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- eluxadoline
pentazocine, eluxadoline. Either increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Avoid coadministration with other drugs that cause constipation. Increases risk for constipation related serious adverse reactions. .
- fentanyl
fentanyl, pentazocine. Either increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Coadministration with other CNS depressants, such as skeletal muscle relaxants, may cause respiratory depression, hypotension, profound sedation, coma, and/or death. Consider dose reduction of either or both agents to avoid serious adverse effects. Monitor for hypotension, respiratory depression, and profound sedation.
pentazocine decreases effects of fentanyl by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Coadministration of mixed agonist/antagonist and partial agonist opioid analgesics may reduce fentanyl's analgesic effect and possibly precipitate withdrawal symptoms. - fentanyl intranasal
fentanyl intranasal, pentazocine. Either increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Coadministration with other CNS depressants, such as skeletal muscle relaxants, may cause respiratory depression, hypotension, profound sedation, coma, and/or death. Consider dose reduction of either or both agents to avoid serious adverse effects. Monitor for hypotension, respiratory depression, and profound sedation.
pentazocine decreases effects of fentanyl intranasal by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Coadministration of mixed agonist/antagonist and partial agonist opioid analgesics may reduce fentanyl's analgesic effect and possibly precipitate withdrawal symptoms. - fentanyl transdermal
fentanyl transdermal, pentazocine. Either increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Coadministration with other CNS depressants, such as skeletal muscle relaxants, may cause respiratory depression, hypotension, profound sedation, coma, and/or death. Consider dose reduction of either or both agents to avoid serious adverse effects. Monitor for hypotension, respiratory depression, and profound sedation.
pentazocine decreases effects of fentanyl transdermal by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Coadministration of mixed agonist/antagonist and partial agonist opioid analgesics may reduce fentanyl's analgesic effect and possibly precipitate withdrawal symptoms. - fentanyl transmucosal
fentanyl transmucosal, pentazocine. Either increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Coadministration with other CNS depressants, such as skeletal muscle relaxants, may cause respiratory depression, hypotension, profound sedation, coma, and/or death. Consider dose reduction of either or both agents to avoid serious adverse effects. Monitor for hypotension, respiratory depression, and profound sedation.
pentazocine decreases effects of fentanyl transmucosal by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Coadministration of mixed agonist/antagonist and partial agonist opioid analgesics may reduce fentanyl's analgesic effect and possibly precipitate withdrawal symptoms. - hydrocodone
pentazocine decreases effects of hydrocodone by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Mixed opioid agonists/antagonists and partial opioid agonists may reduce the analgesic effect of hydrocodone and/or precipitate withdrawal symptoms in opioid tolerant patients.
hydrocodone, pentazocine. Either increases toxicity of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Profound sedation, respiratory depression, coma, and death may result if coadministered. Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate. Limit dosages and durations to the minimum required. Monitor closely for signs of respiratory depression and sedation. - hydromorphone
pentazocine, hydromorphone. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- isocarboxazid
isocarboxazid and pentazocine both increase serotonin levels. Avoid or Use Alternate Drug.
isocarboxazid increases toxicity of pentazocine by unknown mechanism. Avoid or Use Alternate Drug. Risk of hypotension, hyperpyrexia, somnolence, or death; separate by 14 d. - levorphanol
pentazocine, levorphanol. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- linezolid
linezolid and pentazocine both increase serotonin levels. Avoid or Use Alternate Drug. Linezolid may increase serotonin as a result of MAO-A inhibition. If linezolid must be administered, discontinue serotonergic drug immediately and monitor for CNS toxicity. Serotonergic therapy may be resumed 24 hours after last linezolid dose or after 2 weeks of monitoring, whichever comes first.
linezolid increases toxicity of pentazocine by unknown mechanism. Avoid or Use Alternate Drug. Risk of hypotension, hyperpyrexia, somnolence, or death; separate by 14 d. - meperidine
pentazocine, meperidine. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- methadone
pentazocine, methadone. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- methylene blue
methylene blue and pentazocine both increase serotonin levels. Avoid or Use Alternate Drug. Methylene blue may increase serotonin as a result of MAO-A inhibition. If methylene blue must be administered, discontinue pentazocine (if possible) and monitor for CNS toxicity. Serotonergic therapy may be resumed 24 hours after last methylene blue dose or after 2 weeks of monitoring, whichever comes first.
- metoclopramide intranasal
pentazocine, metoclopramide intranasal. Either increases effects of the other by Other (see comment). Avoid or Use Alternate Drug. Comment: Avoid use of metoclopramide intranasal or interacting drug, depending on importance of drug to patient.
- morphine
pentazocine, morphine. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- nalbuphine
nalbuphine, pentazocine. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- oliceridine
pentazocine, oliceridine. Other (see comment). Avoid or Use Alternate Drug. Comment: Concomitant use may reduce analgesic effect of oliceridine and/or precipitate withdrawal symptoms.
- olopatadine intranasal
pentazocine and olopatadine intranasal both increase sedation. Avoid or Use Alternate Drug. Coadministration increases risk of CNS depression, which can lead to additive impairment of psychomotor performance and cause daytime impairment.
- opium tincture
pentazocine, opium tincture. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- oxycodone
pentazocine, oxycodone. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- oxymorphone
pentazocine, oxymorphone. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- ozanimod
ozanimod and pentazocine both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Avoid or Use Alternate Drug. Because the active metabolite of ozanimod inhibits MAO-B in vitro, there is a potential for serious adverse reactions, including hypertensive crisis. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Monitor for hypertension with concomitant use.
- papaveretum
pentazocine, papaveretum. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- phenelzine
phenelzine and pentazocine both increase serotonin levels. Avoid or Use Alternate Drug.
phenelzine increases toxicity of pentazocine by unknown mechanism. Avoid or Use Alternate Drug. Risk of hypotension, hyperpyrexia, somnolence, or death; separate by 14 d. - procarbazine
procarbazine and pentazocine both increase serotonin levels. Avoid or Use Alternate Drug.
procarbazine increases toxicity of pentazocine by unknown mechanism. Avoid or Use Alternate Drug. MAOIs may potentiate CNS depression and hypotension. Do not use within 14 days of MAOI use. . - rasagiline
rasagiline increases toxicity of pentazocine by unknown mechanism. Avoid or Use Alternate Drug. May cause additive CNS depression, drowsiness, dizziness or hypotension, so use with MAOIs should be cautious; lower initial dosages of the analgesic are recommended followed by careful titration. Avoid combination within 14 days of MAOI use.
- selegiline transdermal
selegiline transdermal increases toxicity of pentazocine by unknown mechanism. Avoid or Use Alternate Drug. Risk of hypotension, hyperpyrexia, somnolence, or death.
- selinexor
selinexor, pentazocine. unspecified interaction mechanism. Avoid or Use Alternate Drug. Patients treated with selinexor may experience neurological toxicities. Avoid taking selinexor with other medications that may cause dizziness or confusion.
- sodium oxybate
pentazocine, sodium oxybate. Either increases effects of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Profound sedation, respiratory depression, coma, and death may result if coadministered. Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate. Limit dosages and durations to the minimum required. Monitor closely for signs of respiratory depression and sedation.
- sufentanil
pentazocine, sufentanil. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- sufentanil SL
sufentanil SL, pentazocine. Either increases toxicity of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. Coadministration may result in hypotension, profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate. Limit dosages and durations to the minimum required. Monitor closely for signs of respiratory depression and sedation.
- tapentadol
pentazocine, tapentadol. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx.
- tramadol
tramadol, pentazocine. Other (see comment). Avoid or Use Alternate Drug. Comment: Tramadol may reinitiate opiate dependence in pts. previously addicted to other opiates; it may also provoke withdrawal Sx. in pts. who are currently opiate dependent.
pentazocine, tramadol. Other (see comment). Avoid or Use Alternate Drug. Comment: Mixed opiate agonist/antagonists usually produce additive sedation with narcotics; however, in narcotic addicted pts., the antagonist activity may provoke withdrawal Sx. - tranylcypromine
tranylcypromine and pentazocine both increase serotonin levels. Avoid or Use Alternate Drug.
tranylcypromine increases toxicity of pentazocine by unknown mechanism. Avoid or Use Alternate Drug. Risk of hypotension, hyperpyrexia, somnolence, or death; separate by 14 d. - valerian
valerian and pentazocine both increase sedation. Avoid or Use Alternate Drug.
Monitor Closely (230)
- 5-HTP
5-HTP and pentazocine both increase serotonin levels. Use Caution/Monitor.
- acrivastine
acrivastine and pentazocine both increase sedation. Use Caution/Monitor.
- albuterol
pentazocine increases and albuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- alfentanil
alfentanil and pentazocine both increase sedation. Use Caution/Monitor.
- almotriptan
almotriptan and pentazocine both increase serotonin levels. Use Caution/Monitor.
- alprazolam
alprazolam and pentazocine both increase sedation. Use Caution/Monitor.
- amisulpride
amisulpride and pentazocine both increase sedation. Use Caution/Monitor.
- amitriptyline
pentazocine and amitriptyline both increase sedation. Use Caution/Monitor.
amitriptyline and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - amobarbital
amobarbital and pentazocine both increase sedation. Use Caution/Monitor.
- amoxapine
pentazocine and amoxapine both increase sedation. Use Caution/Monitor.
amoxapine and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - apomorphine
pentazocine and apomorphine both increase sedation. Use Caution/Monitor.
- arformoterol
pentazocine increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- aripiprazole
pentazocine and aripiprazole both increase sedation. Use Caution/Monitor.
- armodafinil
pentazocine increases and armodafinil decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- asenapine
asenapine and pentazocine both increase sedation. Use Caution/Monitor.
- asenapine transdermal
asenapine transdermal and pentazocine both increase sedation. Use Caution/Monitor.
- avapritinib
avapritinib and pentazocine both increase sedation. Use Caution/Monitor.
- azelastine
azelastine and pentazocine both increase sedation. Use Caution/Monitor.
- baclofen
baclofen and pentazocine both increase sedation. Use Caution/Monitor.
- belladonna and opium
belladonna and opium and pentazocine both increase sedation. Use Caution/Monitor.
- benperidol
pentazocine and benperidol both increase sedation. Use Caution/Monitor.
- benzphetamine
pentazocine increases and benzphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- brexanolone
brexanolone, pentazocine. Either increases toxicity of the other by sedation. Use Caution/Monitor.
- brexpiprazole
brexpiprazole and pentazocine both increase sedation. Use Caution/Monitor.
- brimonidine
brimonidine and pentazocine both increase sedation. Use Caution/Monitor.
- brivaracetam
brivaracetam and pentazocine both increase sedation. Use Caution/Monitor.
- brompheniramine
brompheniramine and pentazocine both increase sedation. Use Caution/Monitor.
- buprenorphine
buprenorphine and pentazocine both increase sedation. Use Caution/Monitor.
- buprenorphine buccal
buprenorphine buccal and pentazocine both increase sedation. Use Caution/Monitor.
- buprenorphine, long-acting injection
pentazocine increases toxicity of buprenorphine, long-acting injection by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of buprenorphine and benzodiazepines or other CNS depressants increases risk of adverse reactions including overdose, respiratory depression, and death. Cessation of benzodiazepines or other CNS depressants is preferred in most cases. In some cases, monitoring at a higher level of care for tapering CNS depressants may be appropriate. In others, gradually tapering a patient off of a prescribed benzodiazepine or other CNS depressant or decreasing to the lowest effective dose may be appropriate.
- buspirone
buspirone and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- butabarbital
butabarbital and pentazocine both increase sedation. Use Caution/Monitor.
- butalbital
butalbital and pentazocine both increase sedation. Use Caution/Monitor.
- butorphanol
butorphanol and pentazocine both increase sedation. Use Caution/Monitor.
- caffeine
pentazocine increases and caffeine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- carbinoxamine
carbinoxamine and pentazocine both increase sedation. Use Caution/Monitor.
- carisoprodol
carisoprodol and pentazocine both increase sedation. Use Caution/Monitor.
- cenobamate
cenobamate, pentazocine. Either increases effects of the other by sedation. Use Caution/Monitor.
- chloral hydrate
chloral hydrate and pentazocine both increase sedation. Use Caution/Monitor.
- chlordiazepoxide
chlordiazepoxide and pentazocine both increase sedation. Use Caution/Monitor.
- chlorpheniramine
chlorpheniramine and pentazocine both increase sedation. Use Caution/Monitor.
- chlorpromazine
pentazocine and chlorpromazine both increase sedation. Use Caution/Monitor.
- chlorzoxazone
chlorzoxazone and pentazocine both increase sedation. Use Caution/Monitor.
- cigarette smoking
cigarette smoking decreases effects of pentazocine by increasing metabolism. Use Caution/Monitor. Tobacco smoking may decrease the clinical effect of a standard pentazocine dose.
- cinnarizine
cinnarizine and pentazocine both increase sedation. Use Caution/Monitor.
- citalopram
citalopram and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- clemastine
clemastine and pentazocine both increase sedation. Use Caution/Monitor.
- clomipramine
pentazocine and clomipramine both increase sedation. Use Caution/Monitor.
clomipramine and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - clonazepam
clonazepam and pentazocine both increase sedation. Use Caution/Monitor.
- clorazepate
clorazepate and pentazocine both increase sedation. Use Caution/Monitor.
- clozapine
pentazocine and clozapine both increase sedation. Use Caution/Monitor.
- cocaine topical
cocaine topical and pentazocine both increase serotonin levels. Use Caution/Monitor.
- codeine
codeine and pentazocine both increase sedation. Use Caution/Monitor.
- cyclizine
cyclizine and pentazocine both increase sedation. Use Caution/Monitor.
- cyclobenzaprine
cyclobenzaprine and pentazocine both increase sedation. Use Caution/Monitor.
- cyproheptadine
cyproheptadine and pentazocine both increase sedation. Use Caution/Monitor.
- dantrolene
dantrolene and pentazocine both increase sedation. Use Caution/Monitor.
- daridorexant
pentazocine and daridorexant both increase sedation. Modify Therapy/Monitor Closely. Coadministration increases risk of CNS depression, which can lead to additive impairment of psychomotor performance and cause daytime impairment.
- desflurane
desflurane and pentazocine both increase sedation. Use Caution/Monitor. Opioids may decrease MAC requirements, less inhalation anesthetic may be required.
- desipramine
pentazocine and desipramine both increase sedation. Use Caution/Monitor.
desipramine and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - deutetrabenazine
pentazocine and deutetrabenazine both increase sedation. Use Caution/Monitor.
- dexchlorpheniramine
dexchlorpheniramine and pentazocine both increase sedation. Use Caution/Monitor.
- dexfenfluramine
pentazocine increases and dexfenfluramine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
dexfenfluramine and pentazocine both increase serotonin levels. Use Caution/Monitor. - dexmedetomidine
dexmedetomidine and pentazocine both increase sedation. Use Caution/Monitor.
- dexmethylphenidate
pentazocine increases and dexmethylphenidate decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- dextroamphetamine
pentazocine increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
dextroamphetamine and pentazocine both increase serotonin levels. Use Caution/Monitor. - dextromethorphan
dextromethorphan and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- dextromoramide
dextromoramide and pentazocine both increase sedation. Use Caution/Monitor.
- diamorphine
diamorphine and pentazocine both increase sedation. Use Caution/Monitor.
- diazepam
diazepam and pentazocine both increase sedation. Use Caution/Monitor.
- diethylpropion
pentazocine increases and diethylpropion decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- difelikefalin
difelikefalin and pentazocine both increase sedation. Use Caution/Monitor.
- difenoxin hcl
difenoxin hcl and pentazocine both increase sedation. Use Caution/Monitor.
- dihydroergotamine
dihydroergotamine and pentazocine both increase serotonin levels. Use Caution/Monitor.
- dihydroergotamine intranasal
dihydroergotamine intranasal and pentazocine both increase serotonin levels. Use Caution/Monitor.
- dimenhydrinate
dimenhydrinate and pentazocine both increase sedation. Use Caution/Monitor.
- diphenhydramine
diphenhydramine and pentazocine both increase sedation. Use Caution/Monitor.
- diphenoxylate hcl
diphenoxylate hcl and pentazocine both increase sedation. Use Caution/Monitor.
- dipipanone
dipipanone and pentazocine both increase sedation. Use Caution/Monitor.
- dobutamine
pentazocine increases and dobutamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- dopamine
pentazocine increases and dopamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- dopexamine
pentazocine increases and dopexamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- dosulepin
pentazocine and dosulepin both increase sedation. Use Caution/Monitor.
- doxepin
pentazocine and doxepin both increase sedation. Use Caution/Monitor.
doxepin and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - doxylamine
doxylamine and pentazocine both increase sedation. Use Caution/Monitor.
- droperidol
pentazocine and droperidol both increase sedation. Use Caution/Monitor.
- duloxetine
duloxetine and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- eletriptan
eletriptan and pentazocine both increase serotonin levels. Use Caution/Monitor.
- ephedrine
pentazocine increases and ephedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- epinephrine
pentazocine increases and epinephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- epinephrine racemic
pentazocine increases and epinephrine racemic decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- ergotamine
ergotamine and pentazocine both increase serotonin levels. Use Caution/Monitor.
- escitalopram
escitalopram and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- esketamine intranasal
esketamine intranasal, pentazocine. Either increases toxicity of the other by sedation. Modify Therapy/Monitor Closely.
- estazolam
estazolam and pentazocine both increase sedation. Use Caution/Monitor.
- ethanol
pentazocine and ethanol both increase sedation. Use Caution/Monitor.
- etomidate
etomidate and pentazocine both increase sedation. Use Caution/Monitor.
- fenfluramine
pentazocine increases and fenfluramine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
fenfluramine and pentazocine both increase serotonin levels. Use Caution/Monitor. - flibanserin
pentazocine and flibanserin both increase sedation. Modify Therapy/Monitor Closely. Risk for sedation increased if flibanserin is coadministration with other CNS depressants.
- fluoxetine
fluoxetine and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- fluphenazine
pentazocine and fluphenazine both increase sedation. Use Caution/Monitor.
- flurazepam
flurazepam and pentazocine both increase sedation. Use Caution/Monitor.
- fluvoxamine
fluvoxamine and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- formoterol
pentazocine increases and formoterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- frovatriptan
frovatriptan and pentazocine both increase serotonin levels. Use Caution/Monitor.
- gabapentin
gabapentin, pentazocine. Either increases effects of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of CNS depressants can result in serious, life-threatening, and fatal respiratory depression. Use lowest dose possible and monitor for respiratory depression and sedation.
- gabapentin enacarbil
gabapentin enacarbil, pentazocine. Either increases effects of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of CNS depressants can result in serious, life-threatening, and fatal respiratory depression. Use lowest dose possible and monitor for respiratory depression and sedation.
- ganaxolone
pentazocine and ganaxolone both increase sedation. Use Caution/Monitor.
- haloperidol
pentazocine and haloperidol both increase sedation. Use Caution/Monitor.
- hydromorphone
hydromorphone and pentazocine both increase sedation. Use Caution/Monitor.
- hydroxyzine
hydroxyzine and pentazocine both increase sedation. Use Caution/Monitor.
- iloperidone
pentazocine and iloperidone both increase sedation. Use Caution/Monitor.
- imipramine
pentazocine and imipramine both increase sedation. Use Caution/Monitor.
imipramine and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - isoniazid
isoniazid and pentazocine both increase serotonin levels. Use Caution/Monitor.
- isoproterenol
pentazocine increases and isoproterenol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- ketamine
ketamine and pentazocine both increase sedation. Use Caution/Monitor.
- ketotifen, ophthalmic
pentazocine and ketotifen, ophthalmic both increase sedation. Use Caution/Monitor.
- L-tryptophan
L-tryptophan and pentazocine both increase serotonin levels. Use Caution/Monitor.
- lasmiditan
lasmiditan, pentazocine. Either increases effects of the other by sedation. Use Caution/Monitor. Coadministration of lasmiditan and other CNS depressant drugs, including alcohol have not been evaluated in clinical studies. Lasmiditan may cause sedation, as well as other cognitive and/or neuropsychiatric adverse reactions.
- lemborexant
lemborexant, pentazocine. Either increases effects of the other by sedation. Modify Therapy/Monitor Closely. Dosage adjustment may be necessary if lemborexant is coadministered with other CNS depressants because of potentially additive effects.
- levalbuterol
pentazocine increases and levalbuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- levomilnacipran
levomilnacipran and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- levorphanol
levorphanol and pentazocine both increase sedation. Use Caution/Monitor.
- lisdexamfetamine
pentazocine increases and lisdexamfetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- lithium
lithium and pentazocine both increase serotonin levels. Use Caution/Monitor.
- lofepramine
pentazocine and lofepramine both increase sedation. Use Caution/Monitor.
lofepramine and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - lofexidine
pentazocine and lofexidine both increase sedation. Use Caution/Monitor.
- loprazolam
loprazolam and pentazocine both increase sedation. Use Caution/Monitor.
- lorazepam
lorazepam and pentazocine both increase sedation. Use Caution/Monitor.
- lormetazepam
lormetazepam and pentazocine both increase sedation. Use Caution/Monitor.
- loxapine
pentazocine and loxapine both increase sedation. Use Caution/Monitor.
- loxapine inhaled
pentazocine and loxapine inhaled both increase sedation. Use Caution/Monitor.
- lsd
lsd and pentazocine both increase serotonin levels. Use Caution/Monitor.
- lurasidone
lurasidone, pentazocine. Either increases toxicity of the other by Other (see comment). Use Caution/Monitor. Comment: Potential for increased CNS depressant effects when used concurrently; monitor for increased adverse effects and toxicity.
- maprotiline
pentazocine and maprotiline both increase sedation. Use Caution/Monitor.
maprotiline and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - marijuana
pentazocine and marijuana both increase sedation. Use Caution/Monitor.
- melatonin
pentazocine and melatonin both increase sedation. Use Caution/Monitor.
- meperidine
meperidine and pentazocine both increase sedation. Use Caution/Monitor.
meperidine and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - meprobamate
pentazocine and meprobamate both increase sedation. Use Caution/Monitor.
- metaproterenol
pentazocine increases and metaproterenol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- metaxalone
metaxalone and pentazocine both increase sedation. Use Caution/Monitor.
- methadone
methadone and pentazocine both increase sedation. Use Caution/Monitor.
- methamphetamine
pentazocine increases and methamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- methocarbamol
methocarbamol and pentazocine both increase sedation. Use Caution/Monitor.
- methylenedioxymethamphetamine
pentazocine increases and methylenedioxymethamphetamine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- midazolam
midazolam and pentazocine both increase sedation. Use Caution/Monitor.
- midazolam intranasal
midazolam intranasal, pentazocine. Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Concomitant use of barbiturates, alcohol, or other CNS depressants may increase the risk of hypoventilation, airway obstruction, desaturation, or apnea and may contribute to profound and/or prolonged drug effect.
- midodrine
pentazocine increases and midodrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- milnacipran
milnacipran and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- mirtazapine
pentazocine and mirtazapine both increase sedation. Use Caution/Monitor.
mirtazapine and pentazocine both increase serotonin levels. Use Caution/Monitor. - modafinil
pentazocine increases and modafinil decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- morphine
morphine and pentazocine both increase sedation. Use Caution/Monitor.
morphine and pentazocine both increase serotonin levels. Use Caution/Monitor. - motherwort
pentazocine and motherwort both increase sedation. Use Caution/Monitor.
- moxonidine
pentazocine and moxonidine both increase sedation. Use Caution/Monitor.
- nabilone
pentazocine and nabilone both increase sedation. Use Caution/Monitor.
- nalbuphine
nalbuphine and pentazocine both increase sedation. Use Caution/Monitor.
- naratriptan
naratriptan and pentazocine both increase serotonin levels. Use Caution/Monitor.
- nefazodone
nefazodone and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- norepinephrine
pentazocine increases and norepinephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- nortriptyline
pentazocine and nortriptyline both increase sedation. Use Caution/Monitor.
nortriptyline and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - olanzapine
pentazocine and olanzapine both increase sedation. Use Caution/Monitor.
- oliceridine
oliceridine, pentazocine. Either increases toxicity of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Profound sedation, respiratory depression, coma, and death may result if coadministered. Reserve concomitant prescribing of these drugs in patients for whom other treatment options are inadequate. Limit dosages and durations to the minimum required. Monitor closely for signs of respiratory depression and sedation.
- opium tincture
opium tincture and pentazocine both increase sedation. Use Caution/Monitor.
- orphenadrine
orphenadrine and pentazocine both increase sedation. Use Caution/Monitor.
- oxazepam
oxazepam and pentazocine both increase sedation. Use Caution/Monitor.
- oxycodone
oxycodone and pentazocine both increase sedation. Use Caution/Monitor.
- oxymorphone
oxymorphone and pentazocine both increase sedation. Use Caution/Monitor.
- paliperidone
pentazocine and paliperidone both increase sedation. Use Caution/Monitor.
- papaveretum
papaveretum and pentazocine both increase sedation. Use Caution/Monitor.
- papaverine
pentazocine and papaverine both increase sedation. Use Caution/Monitor.
- paroxetine
paroxetine and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- pegvisomant
pentazocine decreases effects of pegvisomant by unknown mechanism. Use Caution/Monitor.
- pentobarbital
pentobarbital and pentazocine both increase sedation. Use Caution/Monitor.
- perphenazine
pentazocine and perphenazine both increase sedation. Use Caution/Monitor.
- phendimetrazine
pentazocine increases and phendimetrazine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- phenobarbital
phenobarbital and pentazocine both increase sedation. Use Caution/Monitor.
- phentermine
pentazocine increases and phentermine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- phenylephrine
pentazocine increases and phenylephrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- phenylephrine PO
pentazocine increases and phenylephrine PO decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor. .
- pholcodine
pentazocine and pholcodine both increase sedation. Use Caution/Monitor.
- pimozide
pentazocine and pimozide both increase sedation. Use Caution/Monitor.
- pirbuterol
pentazocine increases and pirbuterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- pregabalin
pregabalin, pentazocine. Either increases effects of the other by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Coadministration of CNS depressants can result in serious, life-threatening, and fatal respiratory depression. Use lowest dose possible and monitor for respiratory depression and sedation.
- primidone
primidone and pentazocine both increase sedation. Use Caution/Monitor.
- prochlorperazine
pentazocine and prochlorperazine both increase sedation. Use Caution/Monitor.
- promethazine
promethazine and pentazocine both increase sedation. Use Caution/Monitor.
- propofol
propofol and pentazocine both increase sedation. Use Caution/Monitor.
- propylhexedrine
pentazocine increases and propylhexedrine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- protriptyline
pentazocine and protriptyline both increase sedation. Use Caution/Monitor.
protriptyline and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - quazepam
quazepam and pentazocine both increase sedation. Use Caution/Monitor.
- quetiapine
pentazocine and quetiapine both increase sedation. Use Caution/Monitor.
- ramelteon
pentazocine and ramelteon both increase sedation. Use Caution/Monitor.
- remimazolam
remimazolam, pentazocine. Either increases toxicity of the other by sedation. Modify Therapy/Monitor Closely. Coadministration may result in profound sedation, respiratory depression, coma, and/or death. Continuously monitor vital signs during sedation and recovery period if coadministered. Carefully titrate remimazolam dose if administered with opioid analgesics and/or sedative/hypnotics.
- risperidone
pentazocine and risperidone both increase sedation. Use Caution/Monitor.
- rizatriptan
rizatriptan and pentazocine both increase serotonin levels. Use Caution/Monitor.
- salmeterol
pentazocine increases and salmeterol decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- SAMe
pentazocine and SAMe both increase serotonin levels. Use Caution/Monitor.
- scullcap
pentazocine and scullcap both increase sedation. Use Caution/Monitor.
- secobarbital
secobarbital and pentazocine both increase sedation. Use Caution/Monitor.
- selegiline
selegiline and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. Potential for increased CNS depression, drowsiness, dizziness or hypotension, so use with any MAOI should be cautious.
- selegiline transdermal
selegiline transdermal and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- sertraline
sertraline and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- sevoflurane
sevoflurane and pentazocine both increase sedation. Use Caution/Monitor.
- shepherd's purse
pentazocine and shepherd's purse both increase sedation. Use Caution/Monitor.
- St John's Wort
pentazocine and St John's Wort both increase serotonin levels. Modify Therapy/Monitor Closely.
- stiripentol
stiripentol, pentazocine. Either increases effects of the other by sedation. Use Caution/Monitor. Concomitant use stiripentol with other CNS depressants, including alcohol, may increase the risk of sedation and somnolence.
- sufentanil
pentazocine and sufentanil both increase sedation. Use Caution/Monitor.
- sumatriptan
sumatriptan and pentazocine both increase serotonin levels. Use Caution/Monitor.
- sumatriptan intranasal
sumatriptan intranasal and pentazocine both increase serotonin levels. Use Caution/Monitor.
- suvorexant
suvorexant and pentazocine both increase sedation. Modify Therapy/Monitor Closely. Dosage adjustments of suvorexant and concomitant CNS depressants may be necessary
- tapentadol
pentazocine and tapentadol both increase sedation. Use Caution/Monitor.
- temazepam
temazepam and pentazocine both increase sedation. Use Caution/Monitor.
- terbutaline
pentazocine increases and terbutaline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- thioridazine
pentazocine and thioridazine both increase sedation. Use Caution/Monitor.
- thiothixene
pentazocine and thiothixene both increase sedation. Use Caution/Monitor.
- topiramate
pentazocine and topiramate both increase sedation. Modify Therapy/Monitor Closely.
- tramadol
pentazocine and tramadol both increase sedation. Use Caution/Monitor.
pentazocine and tramadol both increase serotonin levels. Use Caution/Monitor. - trazodone
pentazocine and trazodone both increase sedation. Use Caution/Monitor.
trazodone and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - triazolam
triazolam and pentazocine both increase sedation. Use Caution/Monitor.
- triclofos
triclofos and pentazocine both increase sedation. Use Caution/Monitor.
- trifluoperazine
pentazocine and trifluoperazine both increase sedation. Use Caution/Monitor.
- trimipramine
pentazocine and trimipramine both increase sedation. Use Caution/Monitor.
trimipramine and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely. - triprolidine
triprolidine and pentazocine both increase sedation. Use Caution/Monitor.
- venlafaxine
venlafaxine and pentazocine both increase serotonin levels. Modify Therapy/Monitor Closely.
- xylometazoline
pentazocine increases and xylometazoline decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- yohimbine
pentazocine increases and yohimbine decreases sedation. Effect of interaction is not clear, use caution. Use Caution/Monitor.
- ziconotide
pentazocine and ziconotide both increase sedation. Use Caution/Monitor.
- ziprasidone
pentazocine and ziprasidone both increase sedation. Use Caution/Monitor.
- zolmitriptan
zolmitriptan and pentazocine both increase serotonin levels. Use Caution/Monitor.
- zotepine
pentazocine and zotepine both increase sedation. Use Caution/Monitor.
Minor (9)
- aspirin
aspirin, pentazocine. Either increases toxicity of the other by pharmacodynamic synergism. Minor/Significance Unknown. Possible risk of renal papillary necrosis w/chronic Tx.
- aspirin rectal
aspirin rectal, pentazocine. Either increases toxicity of the other by pharmacodynamic synergism. Minor/Significance Unknown. Possible risk of renal papillary necrosis w/chronic Tx.
- aspirin/citric acid/sodium bicarbonate
aspirin/citric acid/sodium bicarbonate, pentazocine. Either increases toxicity of the other by pharmacodynamic synergism. Minor/Significance Unknown. Possible risk of renal papillary necrosis w/chronic Tx.
- brimonidine
brimonidine increases effects of pentazocine by pharmacodynamic synergism. Minor/Significance Unknown. Increased CNS depression.
- dextroamphetamine
dextroamphetamine increases effects of pentazocine by unspecified interaction mechanism. Minor/Significance Unknown.
- eucalyptus
pentazocine and eucalyptus both increase sedation. Minor/Significance Unknown.
- lidocaine
lidocaine increases toxicity of pentazocine by pharmacodynamic synergism. Minor/Significance Unknown. Risk of increased CNS depression.
- sage
pentazocine and sage both increase sedation. Minor/Significance Unknown.
- ziconotide
ziconotide, pentazocine. Mechanism: unspecified interaction mechanism. Minor/Significance Unknown. Additive decreased GI motility. Additive analgesia. Ziconotide does NOT potentiate opioid induced respiratory depression.
Warnings
Black Box Warnings
Talwin Nx is intended for oral administration only. Severe vascular reactions have resulted from misuse by injection
Contraindications
Hypersensitivity
Do not inject dissolved tablets
If prescribed for long-term use, take precautions to avoid increases in dose by the patient
Pregnancy & Lactation
Pregnancy Category: C
Lactation: use caution
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Images
Formulary
Adding plans allows you to compare formulary status to other drugs in the same class.
To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.
Adding plans allows you to:
- View the formulary and any restrictions for each plan.
- Manage and view all your plans together – even plans in different states.
- Compare formulary status to other drugs in the same class.
- Access your plan list on any device – mobile or desktop.